Delivery Order SPE2DB22D1017-SPE2DB24FF8FS
Award Date 5/23/24
Potential Completion Date 5/24/24
Potential Value $1.2K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of the prescription drug Vyvanse 40mg capsules to the Defense Logistics Agency (DLA), a defense agency of the U.S. government. The contract has a ceiling value of $2,422.08 and is a firm fixed-price delivery order, with a period of performance through July 8, 2024. This award is associated with Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- This federal contract award to Amerisourcebergen Drug Corp is a delivery order valued at $2,603.07 for the supply of Vyvanse 20 mg capsules to the Defense Logistics Agency (DLA). The contract has an ultimate completion date of February 28, 2025 and is a firm fixed price arrangement. Amerisourcebergen, a major pharmaceutical distributor, holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a comprehensive range of pharmaceutical products and...
- This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of Vyvanse 40 mg capsules to the Defense Logistics Agency (DLA). The $1,724.00 firm fixed price delivery order has a completion date of May 17, 2024 and was awarded on May 16, 2024. Amerisourcebergen, a major pharmaceutical distributor, holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a comprehensive range of pharmaceutical products...
- This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of 4564375451 - Vyvanse 20mg capsules, 100s, with a ceiling value of $2,243.03. The contract was awarded on April 23, 2024 by the Defense Logistics Agency (DLA), a defense agency, and has an ultimate completion date of April 24, 2024. The contract is a Delivery Order with a Firm Fixed Price pricing type, and does not have a set-aside designation. Amerisourcebergen, a major pharmaceutical...
- This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distributor, is for the delivery of 40 mg Vyvanse capsules (100 count) to the Defense Logistics Agency (DLA). The $1,809.46 contract is a firm fixed-price delivery order, which is part of Amerisourcebergen's $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. This IDC serves as the primary vehicle for Amerisourcebergen to supply a wide range of...
- This federal contract award to Amerisourcebergen Drug Corp., a major pharmaceutical distributor, is for the supply of Vyvanse 50 mg capsules to the Defense Logistics Agency (DLA) Troop Support Medical. The $5,645.33 delivery order falls under a larger Indefinite Delivery Contract (IDC) with the DLA, valued at up to $999,999,999 through December 2025, for providing a comprehensive range of medical commodities to support military treatment programs and facilities worldwide. The contract has no...
- This federal contract award is for the delivery of 40mg Vyvanse capsules (100 count) to the Defense Logistics Agency (DLA). The contract was awarded to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, and has a ceiling value of $1,171.02. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of October 30, 2024. This award is not designated as a set-aside contract....
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Vyvanse 40 mg capsules. The contract has a ceiling value of $4,700.14 and a period of performance through April 30, 2025. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00, which serves as a comprehensive global pharmaceutical support vehicle through December 2026....
- This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of Vyvanse 10 mg capsules in 100-count bottles. The $4,338.02 firm fixed-price contract was issued by the Defense Logistics Agency (DLA) on May 31, 2024, with a completion date of June 3, 2024. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) the company holds with the DLA, valued up to $999,999,999.00 through December 31, 2025. This single-award IDC serves...
- This federal contract award is a delivery order with a firm fixed price awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The award, valued at $1,502.56, is for the supply of Vyvanse 50 mg capsules. The contract has an ultimate completion date of July 2, 2025 and does not use a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support...